A comparative study of humidification and a nasal spray for the treatment of nasal symptoms experienced by patients using continuous positive airway pressure (CPAP) via a mask
Completed
- Conditions
- ervous System Diseases: obstructive sleep apnoea (OSA)Nervous System DiseasesObstructive sleep apnoea (OSA)
- Registration Number
- ISRCTN75033377
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
32 patients will be recruited from new patients presenting with OSA who are to be treated with CPAP
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie nasal symptom improvement with CPAP humidification in OSA patients?
How does nasal spray therapy compare to CPAP humidification in managing OSA-related nasal congestion?
Are there specific biomarkers that predict response to nasal interventions in obstructive sleep apnoea?
What adverse events are associated with long-term CPAP mask use and how can they be mitigated?
What combination therapies enhance CPAP adherence in patients with nervous system comorbidities?